News
Preliminary results from a different ongoing study suggest that the VeriStrat test may have similar indications in patients with other types of solid tumors. Data from this study is expected to be ...
The Florida Panthers have signed Canadian singer Michael Buble — for a good cause. Buble, a five-time Grammy-winning pop icon ...
The "Make America Healthy Again" report, commissioned by President Trump, highlights ultraprocessed foods and environmental ...
Alcohol associated cancer deaths have doubled in the U.S. over the past three decades, disproportionately impacting men and ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Genmab A/S announced today that it will present new research from its comprehensive development program evaluating its late-stage portfolio at the 2025 American Society of Clinical Oncology (ASCO) ...
Alcohol is a known risk factor for cancer, and new research is showing just how much its impacted cancer mortality rates in the past three decades.
Pelareorep initiates a pro-inflammatory tumor microenvironment (TME) and induces innate and adaptive immune responses New ...
Neel Shah, MD, and Manmeet Ahluwalia, MD, MBA, FASCO, discuss what they look most forward to hearing about and learning at the 2025 ASCO Annual Meeting.
15h
Vietnam Investment Review on MSNEisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual MeetingPRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that the ...
Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results